Full name
"ALBA" MARKETING I KONSULTACJE FARMACEUTYCZNE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
51.10.Z - Passenger air transport
51.21.Z - Air freight transport
52.23.Z - Support activities for air transport
68.10.Z - Real estate activities on own account and development of building projects
77.35.Z - Rental and leasing of air transport equipment
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,8 | 0,3 | -0,1 | -141,6 |
EBITDA | 0,8 | 0,3 | -0,1 | -140,8 |
Short time liabilities | 4,7 | 5,1 | 5 | -1,2 |
Equity capital | 0,7 | 1 | 0,8 | -18,1 |
Operating profit (EBIT) | 0,8 | 0,3 | -0,1 | -141,5 |
Assets | 6,9 | 7,3 | 7,1 | -3,2 |
Net profit (loss) | 0,7 | 0,2 | -0,2 | -181,5 |
Cash | 2,9 | 2,7 | 2,7 | -0,5 |
Net income from sale | 20,9 | 22,9 | 23,7 | 3,4 |
Liabilities and provisions for liabilities | 6,2 | 6,4 | 6,3 | -0,9 |
Working assets | 6,9 | 7,3 | 7,1 | -2,9 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 94,4 | 22,2 | -22 | -44,2 |
Equity capital to total assets | 10,8 | 13,1 | 11,1 | -2 |
Gross profit margin | 3,8 | 1,1 | -0,5 | -1,6 |
EBITDA Margin | 3,8 | 1,2 | -0,5 | -1,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 81 | 80 | 77 | -3 |
Current financial liquidity indicator | 1.472237467765808 | 1.4448498487472534 | 1.4192988872528076 | 0 |
Net dept to EBITDA | -1.5664597749710083 | -4.70058012008667 | 12.995369911193848 | 17,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane